Mario Alfredo Eisenberger, MD
Hematology Oncology
Medical Oncology
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Mario Alfredo Eisenberger
Professional Titles
- R. Dale Hughes Professor of Oncology and Urology
Primary Academic Title
Professor of Oncology
Background
Dr. Mario A. Eisenberger is a medical oncologist at Sibley Memorial Hospital, as well as a professor of urology and oncology at the Johns Hopkins University School of Medicine. He practices out of Sibley Memorial Hospital in Washington, D.C., Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Md. and Johns Hopkins Medicine - Green Spring Station in Lutherville, Md.
Dr. Eisenberger has an expertise in cancers of the bladder, kidney, prostate and testicles.
Dr. Eisenberger earned his medical degree from Federal University of Rio de Janeiro. He completed a residency in internal medicine at Michael Reese Hospital and Medical Center, followed by a hematology fellowship. Dr. Eisenberger also completed a fellowship in medical oncology at Jackson Memorial Hospital. He was previously a senior investigator for the Cancer Therapy Evaluation Program of the National Cancer Institute and chief of oncology at the Baltimore Veterans Administration Hospital. Dr. Dunne has also held faculty appointments at the University of Miami and the University of Maryland.
Dr. Eisenberger has been repeatedly named one of America’s Top Doctors and one of America’s Top Doctors for Cancer by Castle Connolly. He is a member of the American Association of Cancer Research, the National Prostate Cancer Education Council and the International Task Force of the American Society of Clinical Oncology.
Dr. Eisenberger has contributed to numerous clinical trials, publications and presentations. He has presented on the systemic treatment of prostate cancer for the President’s Cancer Panel and was a participant in the World Health Organization international panel to update directives and standardize methodology of clinical trials in advanced prostate cancer. Dr. Eisenberger has also won the Clinical Investigator Award by the Prostate Cancer Foundation.
Centers and Institutes
- Brady Urological Institute
- Johns Hopkins Greenberg Bladder Cancer Institute
- Sidney Kimmel Comprehensive Cancer Center
- The Johns Hopkins Precision Medicine Center of Excellence for Prostate Cancer
Clinical Trial Keywords
prostate cancer
Additional Academic Titles
Professor of Urology
Research Interests
Bladder cancer, General internal medicine, Kidney cancer, Medical oncology, Prostate cancer, Testicular cancer, Urological oncology
Selected Publications
- Peer A, Gottfried M, Sinibaldi V, Carducci MA, Eisenberger MA, Sella A, Leibowitz-Amit R, Berger R, Keizman D. “Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel.” Prostate. 2013 Dec 11. doi: 10.1002/pros.22765. [Epub ahead of print].
- Keizman D, Gottfried M, Ish-Shalom M, Maimon N, Peer A, Neumann A, Hammers H, Eisenberger MA, Sinibaldi V, Pili R, Hayat H, Kovel S, Sella A, Boursi B, Weitzen R, Mermershtain W, Rouvinov K, Berger R, Carducci MA. “Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib.” Oncologist. 2013 Dec 5. [Epub ahead of print].
- Paller CJ, Antonarakis ES, Eisenberger MA, Carducci MA. “Management of patients with biochemical recurrence after local therapy for prostate cancer.” Hematol Oncol Clin North Am. 2013 Dec;27(6):1205-19, viii. doi: 10.1016/j.hoc.2013.08.005. Epub 2013 Sep 18.
- Suzman DL, Eisenberger MA. “Determining the Optimal Treatment for Metastatic Castration-resistant Prostate Cancer: Age Should Not Be a Factor.” Eur Urol. 2013 Oct 16. pii: S0302-2838(13)01075-0. doi: 10.1016/j.eururo.2013.10.002. [Epub ahead of print]
- Pond GR, Sonpavde G, de Wit R, Eisenberger MA, Tannock IF, Armstrong AJ. ‘The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer.” Eur Urol. 2014 Jan;65(1):3-6. doi: 10.1016/j.eururo.2013.09.024. Epub 2013 Oct 5.
Honors
- Clinical Investigator Award, Prostate Cancer Foundation, 1/1/04
- Plenary Presentation, American Society of Clinical Oncology, New Orleans, LA, 1/1/04
- R. Dale Hughes Distinguished Professor of Oncology, The Johns Hopkins University, 1/1/02
- Listed in Best Doctors of America, 1/1/00
- Plenary Presentation, American Society of Clinical Oncology, Denver CO, 1/1/97
- Who's Who in the World, 1/1/95
- Participant in World Health Organization international panel to update directives and standardize methodology of clinical trials in advanced prostate cancer, 1/1/95
- Selected to present on the systemic treatment of prostate cancer for the President's Cancer Panel, 1/1/92
- Selected as member of Prostate Cancer Education Council, 1/1/89
- Participant in NIH Consensus Conference in Prostate Cancer, 1/1/87
Memberships
- American Association of Cancer Research
- American Society of Clinical Oncology
- National Prostate Cancer Education Council
Locations
- The Johns Hopkins Hospital
- 1800 Orleans Street, Baltimore, MD 21287
- phone: 410-955-5000
- fax: 410-955-5001
Expertise
Education
University of Miami Jackson Health
Fellowship, Medical Oncology, 1978Michael Reese Hospital and Medical Center
Fellowship, Hematology, 1976Michael Reese Hospital and Medical Center
Residency, Internal Medicine, 1975Universidade Federal do Rio de Janeiro (UFRJ)
Medical Education, MD, 1972Board Certifications
Medical Oncology
American Board of Internal Medicine, 1979Internal Medicine
American Board of Internal Medicine, 1976Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)